Date Title Statement Presentation Report Webcast
26 March 2018

Phase 2b COPD four week study top-line data presentation

  Presentation    
7 September 2017

Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)

  Presentation    
27 February 2017

Annual report 2016

    Report  
12 September 2016

Interim report 2016

    Report  
2 June 2016

Annual report 2015

    Report  
2 June 2016

Audited results 2015

  Presentation    
7 September 2015

Interim report 2015

    Report  
11 May 2015

Annual report 2014

    Report  
11 May 2015

Audited results 2014

  Presentation    
9 September 2014

Interim report 2014

    Report  
Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us